Literature DB >> 7793178

Identification of human plasma cholinesterase variants using molecular biological techniques.

F S Jensen1, M Schwartz, J Viby-Mogensen.   

Abstract

Genetic variation is one of several factors determining the level and quality of plasma cholinesterase activity (butyrylcholinesterase, BChE). The many genetic variants known today, and the resulting large number of genotypes and phenotypes, have complicated the problem of identifying individual BChE genotypes and phenotypes on the basis of enzymatic analyses alone. Modern molecular biological techniques have, however, permitted the development of diagnostic tests which allow BChE variants to be identified at the DNA level. Today, at least 20 genetic variants have been identified in this way. This review is an introduction to the principles of molecular biology used to identify the variants forms of the BCHE gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793178     DOI: 10.1111/j.1399-6576.1995.tb04033.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

1.  Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase.

Authors:  A S Balasubramanian
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

2.  Prolonged neuromuscular blockade following succinylcholine administration to a patient with a reduced butyrylcholinesterase activity.

Authors:  Ivo F Panhuizen; Marc M J Snoeck; Soledad Levano; Thierry Girard
Journal:  Case Rep Med       Date:  2010-06-17

3.  Pseudocholinesterase Enzyme Deficiency in Adıyaman City Area.

Authors:  Ruslan Abdullayev; Ömer Burak Küçükebe; Recai Kaya; Bülent Çelik; Hatice Kuşderci; Mehmet Duran; Öznur Uludağ; Mesut Öterkuş; Aysel Buyrukcan; Ülkü Sabuncu; Abdullah Arpacı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.